Que Dallara is recorded as Board Member at MiniMed Group, Inc. (MMED) since March 6, 2026 and CEO at MiniMed Group, Inc. (MMED). The newest filing on record that lists Que Dallara as CEO at MiniMed Group, Inc. (MMED) is dated August 21, 2026. MiniMed Group, Inc. reported in an 8-K filed March 9, 2026 that Que Dallara was appointed Chief Executive Officer and Director Nominee, effective March 6, 2026. MiniMed Group, Inc. reported in an 8-K filed March 9, 2026 that Que Dallara was appointed members of the Board, effective March 6, 2026. The proxy statement of MiniMed Group, Inc. reports total compensation of $8,430,228 for Que Dallara in fiscal 2026, including a base salary of $810,769. Disclosed compensation is on record for 2 fiscal years. Que Dallara has spoken on 1 investor event across 1 company, most recently for MiniMed Group, Inc. on September 23, 2026. MiniMed Group, Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at MiniMed Group, Inc. includes D. Keith Grossman (CEO and Board Member), David Endicott (CEO and Board Member), Kevin E. Lofton (Chairman) and 7 others.
“as of March 6, 2026, all of the officers of the Company were removed and the following individuals became officers of the Company: Que Dallara | Chief Executive Officer and Director Nominee”
MiniMed Group, Inc. Form 8-K, filed March 9, 2026
· Read the filing
“Kevin E. Lofton was appointed as Chair of the Board, and Que Dallara, Glenn Eisenberg, D. Keith Grossman, Robert (Bob) A. Hopkins, Laura Mauri, Brett A. Wall, Matthew (Matt) R. Walter, and Timothy (Tim) A. Wicks were appointed as members of the Board.”
MiniMed Group, Inc. Form 8-K, filed March 9, 2026
· Read the filing
Que Dallara on recent calls
“What's really fundamentally changed, I would say, is really two things. One is we've really kicked it up a gear.”
